LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.24 | 17.25 | 6184 | 4929 | 1.2546 | 1.0564 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.24 | 17.25 | 1400 | 4929 | 0.2840 | 0.7141 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 56.24 | 17.25 | 6644 | 4929 | 1.3479 | 1.0745 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.21 | 17.25 | 2807 | 4942 | 0.5679 | 0.8661 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.21 | 17.25 | 6668 | 4942 | 1.3491 | 1.0747 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.21 | 17.25 | 1197 | 4942 | 0.2422 | 0.6811 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 58.21 | 17.25 | 7220 | 4942 | 1.4608 | 1.0951 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.18 | 17.25 | 2544 | 5031 | 0.5056 | 0.8402 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.18 | 17.25 | 7045 | 5031 | 1.4002 | 1.0839 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.18 | 17.25 | 1043 | 5031 | 0.2073 | 0.6503 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 60.18 | 17.25 | 7684 | 5031 | 1.5272 | 1.1061 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.15 | 17.25 | 2594 | 5061 | 0.5125 | 0.8434 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.15 | 17.25 | 7371 | 5061 | 1.4564 | 1.0939 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.15 | 17.25 | 570 | 5061 | 0.1126 | 0.5322 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.15 | 17.25 | 8130 | 5061 | 1.6064 | 1.1191 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.12 | 17.25 | 2526 | 5095 | 0.4958 | 0.8361 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.12 | 17.25 | 7725 | 5095 | 1.5161 | 1.1040 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.12 | 17.25 | 452 | 5095 | 0.0887 | 0.4888 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.12 | 17.25 | 8556 | 5095 | 1.6792 | 1.1304 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.09 | 17.25 | 2391 | 5221 | 0.4580 | 0.8192 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.09 | 17.25 | 8017 | 5221 | 1.5355 | 1.1068 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.09 | 17.25 | 327 | 5221 | 0.0626 | 0.4290 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.09 | 17.25 | 8906 | 5221 | 1.7058 | 1.1339 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 69.06 | 17.25 | 2346 | 5242 | 0.4475 | 0.8142 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 69.06 | 17.25 | 8275 | 5242 | 1.5784 | 1.1138 | MN20160310_N02 | E03 |